Self-administration of intranasal influenza vaccine: Immunogenicity and volunteer acceptance
Timothy Burgess(Uniformed Services University of the Health Sciences), Eugene V. Millar(Uniformed Services University of the Health Sciences), Elizabeth R. Zell(St. Johns Center for Clinical Research), Kanakatte Raviprakash, Jessica G. Rosas(Brooke Army Medical Center), Mary Bavaro, Nicholas J. Martin(Naval Medical Research Command), Clinton K. Murray(Joint Commission), Thomas O’Bryan(Henry M. Jackson Foundation), Kenneth J. Wilkins(National Institutes of Health), Stephanie Cammarata(Naval Medical Center San Diego), Deepika Mor(Henry M. Jackson Foundation), Michael L. Landrum(San Antonio Military Medical Center), Daniel Ewing(Naval Medical Research Command)
Cited by 22
Related Papers
Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza
|BMC Infectious Diseases|2015|514
Trimethoprim-Sulfamethoxazole Revisited
|Archives of Internal Medicine|2003|401
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia
|Emerging infectious diseases|2016|259
Invasive Mold Infections Following Combat-related Injuries
|Clinical Infectious Diseases|2012|191